Skip to Main Content
Pharmacy Technician's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • National Certification
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Respiratory & Allergy
  4. COPD
  5. Treatment

Treatment

  • Allergic Reactions (123)
  • Allergic Rhinitis (54)
  • Asthma (149)
  • Autoimmune Disorders (3)
  • COPD (117)
    • Immunizations (30)
    • Interactions (8)
    • Treatment (94)
  • Cystic Fibrosis (4)
  • Ear Health (13)
  • Ear, Nose & Throat (36)
  • E-Cigarettes (1)
  • Immunology (3)
  • Inhalers (33)
  • Other (14)
  • Otolaryngology (20)
  • Pulmonary (11)
  • Resources (232)
  • Respiratory Infections (359)
  • Sleep Apnea (12)
  • Smoking (19)
  • Smoking Cessation (106)
61 - 75 of 94 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Market Withdrawal of Primatene Mist (Epinephrine) Inhalers November 2011
Other: FDA Podcast: Withdrawal of Primatene Mist (April 2011) November 2011
Article: Daliresp (DA-li-resp, roflumilast), a new oral tab for people with severe chronic obstructive pulmonary disease (COPD) July 2011
Commentary: New Drug: Daliresp (Roflumilast) July 2011
Guideline: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2010) July 2011
Article: generic levofloxacin (Levaquin) tablets that are coming in June May 2011
Chart: Comparison of Quinolone Antibiotics May 2011
Guideline: Adult Sinusitis (2007) May 2011
Guideline: Treatment of Community Acquired Pneumonia (1999) May 2011
Guideline: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2010) May 2011
Guideline: NAEPP Guidelines for the Diagnosis and Management of Asthma – Summary Report 2007 April 2010
Commentary: Should Inhalers Be Stored Upright? April 2010
Article: whether certain inhalers need to be stored upright April 2010
Article: whether it's okay to mix albuterol and ipratropium nebulizer solutions March 2010
Article: alerting patients to short expiration dates with inhalers September 2009
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
© Therapeutic Research Center. All Rights Reserved